Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BMcV who wrote (2542)	4/27/1999 2:00:00 PM
From: Biomaven	Read Replies (1) of 10280

>>Sepracor's (R,R)-Formoterol Phase IIA Study Complete Not sure why they compared (R,R)formoterol to Ventolin (which is our old friend albuterol). The obvious comparison is of course to formoterol itself. However based on what I know about formoterol, the results looked good. Formoterol seems generally viewed as having a 12 hour effect, so improving this to 24 hours would certainly be significant. Formoterol is generally described as having a fairly quick onset of action, but I'm not sure I've ever seen it described as immediate. Formoterol typically has the same sort of side-effect profile as albuterol. Still fairly early, but this could be another significant drug for SEPR. On another topic, the ML bond/stock hybrid was interesting. Might be a good investment for an IRA for someone who needs to be down-side risk averse. Certainly an expression of confidence by ML in SEPR to include it with PFE and WLA. (BTW, these are the only 3 stocks involved, although the release seems to imply there are also others). Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next